Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Sherwin Stephen A exercised options for 3,318 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 21, 2026 · Filed May 21, 2026
On May 21, 2026, Sherwin Stephen A (Director) exercised options for 3,318 Neurocrine Biosciences, Inc. shares, leaving 15,860 shares. Filed May 21, 2026 (Form 4).
- Options exercised
- 3,318 shares
- Holding after
- 15,860 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Option exercise | 3,318 | 15,860 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Sherwin Stephen A
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Sherwin Stephen A · Sep 3, 2026
- Form 4 · Sherwin Stephen A · Jun 9, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026